FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Phase III   Biotech Stock   Generics   Phase II
Syndicate content

private placement News

Most Popular private placement Story

ALSO NOTED: Nycomed, Ceremed sign deal; Optimer raises $35.9M in private placement; GSK braces for cuts; and much more...

> Nycomed and Ceremed have signed a licensing and distribution pact for Ostene, a product designed to stop bone bleeding in surgery. Read more...

Latest Headlines